Therapeutic considerations in renal plasmacytoma

W. J. Catalona, J. D. Biles

Research output: Contribution to journalArticle

Abstract

Primary plasmacytomas present as solitary lesions but systemic dissemination ultimately occurs in the vast majority of cases. Although organs rich in reticuloendothelial elements are the most common sites of secondary involvement, organs of the urogenital system are also frequently involved. Treatment programs should include systemic chemotherapy with alkylating agents. Primary operative therapy is seldom indicated in renal plasmacytoma and preservation of all functioning renal tissue is essential.

Original languageEnglish (US)
Pages (from-to)582-583
Number of pages2
JournalJournal of Urology
Volume111
Issue number5
StatePublished - 1974

Fingerprint

Plasmacytoma
Urogenital System
Kidney
Alkylating Agents
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Urology

Cite this

Catalona, W. J., & Biles, J. D. (1974). Therapeutic considerations in renal plasmacytoma. Journal of Urology, 111(5), 582-583.

Therapeutic considerations in renal plasmacytoma. / Catalona, W. J.; Biles, J. D.

In: Journal of Urology, Vol. 111, No. 5, 1974, p. 582-583.

Research output: Contribution to journalArticle

Catalona, WJ & Biles, JD 1974, 'Therapeutic considerations in renal plasmacytoma', Journal of Urology, vol. 111, no. 5, pp. 582-583.
Catalona WJ, Biles JD. Therapeutic considerations in renal plasmacytoma. Journal of Urology. 1974;111(5):582-583.
Catalona, W. J. ; Biles, J. D. / Therapeutic considerations in renal plasmacytoma. In: Journal of Urology. 1974 ; Vol. 111, No. 5. pp. 582-583.
@article{759a98d242f34e24b281cfb2f4c18470,
title = "Therapeutic considerations in renal plasmacytoma",
abstract = "Primary plasmacytomas present as solitary lesions but systemic dissemination ultimately occurs in the vast majority of cases. Although organs rich in reticuloendothelial elements are the most common sites of secondary involvement, organs of the urogenital system are also frequently involved. Treatment programs should include systemic chemotherapy with alkylating agents. Primary operative therapy is seldom indicated in renal plasmacytoma and preservation of all functioning renal tissue is essential.",
author = "Catalona, {W. J.} and Biles, {J. D.}",
year = "1974",
language = "English (US)",
volume = "111",
pages = "582--583",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Therapeutic considerations in renal plasmacytoma

AU - Catalona, W. J.

AU - Biles, J. D.

PY - 1974

Y1 - 1974

N2 - Primary plasmacytomas present as solitary lesions but systemic dissemination ultimately occurs in the vast majority of cases. Although organs rich in reticuloendothelial elements are the most common sites of secondary involvement, organs of the urogenital system are also frequently involved. Treatment programs should include systemic chemotherapy with alkylating agents. Primary operative therapy is seldom indicated in renal plasmacytoma and preservation of all functioning renal tissue is essential.

AB - Primary plasmacytomas present as solitary lesions but systemic dissemination ultimately occurs in the vast majority of cases. Although organs rich in reticuloendothelial elements are the most common sites of secondary involvement, organs of the urogenital system are also frequently involved. Treatment programs should include systemic chemotherapy with alkylating agents. Primary operative therapy is seldom indicated in renal plasmacytoma and preservation of all functioning renal tissue is essential.

UR - http://www.scopus.com/inward/record.url?scp=0016371946&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016371946&partnerID=8YFLogxK

M3 - Article

C2 - 4132784

AN - SCOPUS:0016371946

VL - 111

SP - 582

EP - 583

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 5

ER -